Olopatadine Hydrochloride Ophthalmic Solution
- Product NDC
- 43598-764
- 11-digit product format
- 435980764
- Labeler code
- 43598
- Product ID
- 43598-764_bdf7e94a-e260-6ba4-3545-aac867c9dade
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Olopatadine Hydrochloride Ophthalmic
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Labeler
- Dr. Reddy's Laboratories Inc.
- Application
- ANDA209752
- Marketing category
- ANDA
- Marketing start
- 2020-09-01
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| unfinished product | product | 43598-764 | UNFINISHED | Active or certified unfinished drug listing | 2026-08-17 | ||
| unfinished package | package | 43598-764 | 43598-764-10 | UNFINISHED | Active or certified unfinished drug listing | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished product | product | a6255e0c9aa5… | a0211a219f2e… | |
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished package | package | 43598-764-10 | a6255e0c9aa5… | a0211a219f2e… |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished product | product | 1d862106b807… | 00c93037cd84… | |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished package | package | 43598-764-10 | 1d862106b807… | 00c93037cd84… |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished product | product | 390b4c401c3f… | 2c692c2daee3… | |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished package | package | 43598-764-10 | 390b4c401c3f… | 2c692c2daee3… |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished product | product | e30019b0c005… | a3f0b14938b7… | |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 43598-764-10 | e30019b0c005… | a3f0b14938b7… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished product | product | bbbc9f937eca… | 946b9c97cf81… | |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 43598-764-10 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 43598-764-10 | f268b84574a6… | 26285f5ac5df… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | f764e8902f78… | 92046438deef… | |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished package | package | 43598-764-10 | f764e8902f78… | 92046438deef… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished package | package | 43598-764-10 | 68b1e3bced9e… | 98a755eb8bc6… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 43598-764-10 | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 43598-764-10 | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 43598-764-10 | 27f29a85d7e4… | 1372111e901f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 43598-764-10 | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 43598-764-10 | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 43598-764-10 | 50b4072663b7… | eae3003ed65e… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | unfinished product | product | 906f6e251498… | bf70b80e44f0… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | unfinished package | package | 43598-764-10 | 906f6e251498… | bf70b80e44f0… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | unfinished product | product | 6db9cb8d1e19… | 3449e1ec5b70… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | unfinished package | package | 43598-764-10 | 6db9cb8d1e19… | 3449e1ec5b70… |
| 2021-02-18 23:40 UTC · source 2021-02-18 | unfinished product | product | 8fc7167e32ce… | e96bbc724034… | |
| 2021-02-18 23:40 UTC · source 2021-02-18 | unfinished package | package | 43598-764-10 | 8fc7167e32ce… | e96bbc724034… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | unfinished product | product | 4184dd79f89f… | 545327b3e20f… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | unfinished package | package | 43598-764-10 | 4184dd79f89f… | 545327b3e20f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209752-001 | OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | c0c555d07b60… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209752-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-05-20 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olopatadine Hydrochloride Ophthalmic Solution
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OLOPATADINE HYDROCHLORIDE | 2 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2XG66W44KF | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1111343 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f249d79e-0f62-d2f1-bcbc-22dda253aad2 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-764-02 | ML - Milliliter | 43598-764 | 1f7edda1-b895-40f0-baf1-d7643e4f8101 | 1 | 2022-05-04 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | 135bb2de-b2c0-6f0c-6204-3acbb48dcfbd | 8 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | 135bb2de-b2c0-6f0c-6204-3acbb48dcfbd | 8 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | 135bb2de-b2c0-6f0c-6204-3acbb48dcfbd | 8 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | 135bb2de-b2c0-6f0c-6204-3acbb48dcfbd | 8 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | b233bf3d-e6e6-a724-efd9-389b8e36d2f9 | 6 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | b233bf3d-e6e6-a724-efd9-389b8e36d2f9 | 6 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | b233bf3d-e6e6-a724-efd9-389b8e36d2f9 | 6 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | b233bf3d-e6e6-a724-efd9-389b8e36d2f9 | 6 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | 685192af-d729-3066-5825-6d0e03ce787e | 5 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | 685192af-d729-3066-5825-6d0e03ce787e | 5 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | 685192af-d729-3066-5825-6d0e03ce787e | 5 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | 685192af-d729-3066-5825-6d0e03ce787e | 5 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | 0cb0bb66-def2-35d4-7fe0-987757095d08 | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | d9a01be0-218b-b2b9-1cbf-14a9c160ceb2 | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | e3153a5a-35ca-6c10-eec0-8347c2da121f | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | f249d79e-0f62-d2f1-bcbc-22dda253aad2 | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | fb2f06ee-4d50-5e4e-80c9-d2d9fbf4e6a7 | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | fd0e681a-f217-1a97-e9a7-d740816234ff | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | f249d79e-0f62-d2f1-bcbc-22dda253aad2 | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | fb2f06ee-4d50-5e4e-80c9-d2d9fbf4e6a7 | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | e3153a5a-35ca-6c10-eec0-8347c2da121f | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | fd0e681a-f217-1a97-e9a7-d740816234ff | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | 0cb0bb66-def2-35d4-7fe0-987757095d08 | 4 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | d9a01be0-218b-b2b9-1cbf-14a9c160ceb2 | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | f249d79e-0f62-d2f1-bcbc-22dda253aad2 | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | fb2f06ee-4d50-5e4e-80c9-d2d9fbf4e6a7 | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | fd0e681a-f217-1a97-e9a7-d740816234ff | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | e3153a5a-35ca-6c10-eec0-8347c2da121f | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | d9a01be0-218b-b2b9-1cbf-14a9c160ceb2 | 4 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | 0cb0bb66-def2-35d4-7fe0-987757095d08 | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | e3153a5a-35ca-6c10-eec0-8347c2da121f | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | 0cb0bb66-def2-35d4-7fe0-987757095d08 | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | fd0e681a-f217-1a97-e9a7-d740816234ff | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | fb2f06ee-4d50-5e4e-80c9-d2d9fbf4e6a7 | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | d9a01be0-218b-b2b9-1cbf-14a9c160ceb2 | 4 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | f249d79e-0f62-d2f1-bcbc-22dda253aad2 | 4 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | fa75f236-0170-e7be-ce8c-7dff7c36fac8 | 3 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | f6d70b01-941b-b796-ceee-7f24b6038e7d | 3 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | f6d70b01-941b-b796-ceee-7f24b6038e7d | 3 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | fa75f236-0170-e7be-ce8c-7dff7c36fac8 | 3 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | f6d70b01-941b-b796-ceee-7f24b6038e7d | 3 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | fa75f236-0170-e7be-ce8c-7dff7c36fac8 | 3 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | f6d70b01-941b-b796-ceee-7f24b6038e7d | 3 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | fa75f236-0170-e7be-ce8c-7dff7c36fac8 | 3 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | 56d4b17c-bc5d-0734-32c9-bb10ec77f7b4 | 2 |
| 1111343 | olopatadine HCl 0.2 % Ophthalmic Solution | PSN | 9a9f38fc-af2c-bc7c-abe4-8ad58d51f2e2 | 2 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | 9a9f38fc-af2c-bc7c-abe4-8ad58d51f2e2 | 2 |
| 1111343 | olopatadine 2 MG/ML Ophthalmic Solution | SCD | 56d4b17c-bc5d-0734-32c9-bb10ec77f7b4 | 2 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | 56d4b17c-bc5d-0734-32c9-bb10ec77f7b4 | 2 |
| 1111343 | olopatadine 0.2 % Ophthalmic Solution | SY | 9a9f38fc-af2c-bc7c-abe4-8ad58d51f2e2 | 2 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | 56d4b17c-bc5d-0734-32c9-bb10ec77f7b4 | 2 |
| 1111343 | olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution | SY | 9a9f38fc-af2c-bc7c-abe4-8ad58d51f2e2 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 43598-764-02 | 43598076402 | 1 BOTTLE, PLASTIC in 1 CARTON (43598-764-02) / 2.5 mL in 1 BOTTLE, PLASTIC | 2020-09-01 | 0000-00-00 | No | No | Current |
| 43598-764-10 | 43598076410 | 1000 BOTTLE, PLASTIC in 1 CASE (43598-764-10) / 2.5 mL in 1 BOTTLE, PLASTIC | 19-AUG-20 | Current | |||
| 43598-764-25 | 43598076425 | 2 BOTTLE, PLASTIC in 1 CARTON (43598-764-25) / 2.5 mL in 1 BOTTLE, PLASTIC | 2020-09-01 | 0000-00-00 | No | No | Current |